Marcelo M Gutierrez

Summary

Affiliation: Forest Research Institute
Country: USA

Publications

  1. ncbi request reprint An evaluation of the potential for pharmacokinetic interaction between escitalopram and the cytochrome P450 3A4 inhibitor ritonavir
    Marcelo M Gutierrez
    Forest Laboratories, Inc, New York, New York, USA
    Clin Ther 25:1200-10. 2003
  2. ncbi request reprint A randomized, placebo-controlled trial of citalopram for the treatment of major depression in children and adolescents
    Karen Dineen Wagner
    Department of Psychiatry and Behavioral Sciences, University of Texas Medical Branch, Galveston, TX 77755, USA
    Am J Psychiatry 161:1079-83. 2004

Detail Information

Publications2

  1. ncbi request reprint An evaluation of the potential for pharmacokinetic interaction between escitalopram and the cytochrome P450 3A4 inhibitor ritonavir
    Marcelo M Gutierrez
    Forest Laboratories, Inc, New York, New York, USA
    Clin Ther 25:1200-10. 2003
    ....
  2. ncbi request reprint A randomized, placebo-controlled trial of citalopram for the treatment of major depression in children and adolescents
    Karen Dineen Wagner
    Department of Psychiatry and Behavioral Sciences, University of Texas Medical Branch, Galveston, TX 77755, USA
    Am J Psychiatry 161:1079-83. 2004
    ..The current study investigated the efficacy and safety of citalopram compared with placebo in the treatment of pediatric patients with major depression...